þ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarter Ended September 30, 2006. | |
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from ___to ___ |
Commission file number |
001-13790 |
HCC Insurance Holdings, Inc. | ||||
(Exact name of registrant as specified in its charter) | ||||
Delaware | 76-0336636 | |||
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) | |||
13403 Northwest Freeway, Houston, Texas | 77040-6094 | |||
(Address of principal executive offices) | (Zip Code) | |||
(713) 690-7300 | ||||
(Registrants telephone number, including area code) |
Yes þ |
No o |
Large accelerated filer þ |
Accelerated filer o | Non-accelerated filer o |
Yes o |
No þ |
1
2
| the effects of catastrophic losses; | ||
| the cyclical nature of the insurance business; | ||
| inherent uncertainties in the loss estimation process, which can adversely impact the adequacy of loss reserves; | ||
| the effects of emerging claim and coverage issues; | ||
| the effects of extensive governmental regulation of the insurance industry; | ||
| potential credit risk with brokers; | ||
| our increased retention of risk, which could expose us to greater potential losses; | ||
| the adequacy of reinsurance protection; | ||
| the ability or willingness of reinsurers to pay balances due us; | ||
| the occurrence of terrorist activities; | ||
| our ability to maintain our competitive position; | ||
| changes in our assigned financial strength ratings; | ||
| our ability to raise capital in the future; | ||
| attraction and retention of qualified employees; | ||
| fluctuations in the fixed income securities market, which may reduce the value of our investment assets; | ||
| our ability to successfully expand our business through the acquisition of insurance-related companies; | ||
| our ability to receive dividends from our insurance company subsidiaries in needed amounts; | ||
| fluctuations in foreign exchange rates; | ||
| failures of our information technology systems, which could adversely affect our business; |
3
| developments in the SECs informal inquiry related to our past practices in connection with grants of stock options; | ||
| potential issues related to the effects of Sections 409A and 162(m) of the Internal Revenue Code and any expenses associated therewith; | ||
| changes to improve our internal controls related to the process of granting, documenting and accounting for stock option awards; | ||
| additional expenses and taxes associated with our stock option investigation and related matters; | ||
| potential litigation that could result from our stock option investigation; | ||
| the ability of our Executive Officers to define and implement a strategic business plan; and | ||
| our ability to cure all defaults or events of default under our outstanding loan agreements. |
4
September 30, | December 31, | |||||||
2006 | 2005 | |||||||
ASSETS |
||||||||
Investments: |
||||||||
Fixed income securities, at fair value
(amortized cost: 2006 $2,840,047; 2005 $2,277,139) |
$ | 2,840,610 | $ | 2,268,624 | ||||
Short-term investments, at cost, which approximates fair value |
673,406 | 839,581 | ||||||
Other investments, at fair value (cost: 2006 - $275,644; 2005 - $144,897) |
290,363 | 149,223 | ||||||
Total investments |
3,804,379 | 3,257,428 | ||||||
Cash |
59,638 | 73,935 | ||||||
Restricted cash and cash investments |
171,501 | 170,978 | ||||||
Premium, claims and other receivables |
867,127 | 884,654 | ||||||
Reinsurance recoverables |
1,305,952 | 1,361,983 | ||||||
Ceded unearned premium |
244,003 | 239,416 | ||||||
Ceded life and annuity benefits |
72,429 | 73,415 | ||||||
Deferred policy acquisition costs |
181,111 | 156,253 | ||||||
Goodwill |
554,430 | 532,947 | ||||||
Other assets |
283,669 | 277,791 | ||||||
Total assets |
$ | 7,544,239 | $ | 7,028,800 | ||||
LIABILITIES |
||||||||
Loss and loss adjustment expense payable |
$ | 2,907,626 | $ | 2,813,720 | ||||
Life and annuity policy benefits |
72,429 | 73,415 | ||||||
Reinsurance balances payable |
139,384 | 176,954 | ||||||
Unearned premium |
924,518 | 807,109 | ||||||
Deferred ceding commissions |
67,231 | 67,886 | ||||||
Premium and claims payable |
684,660 | 753,859 | ||||||
Notes payable |
393,167 | 309,543 | ||||||
Accounts payable and accrued liabilities |
394,016 | 335,879 | ||||||
Total liabilities |
5,583,031 | 5,338,365 | ||||||
SHAREHOLDERS EQUITY |
||||||||
Common stock, $1.00 par value; 250.0 million shares authorized
(shares issued and outstanding: 2006 111,491; 2005 110,803) |
111,491 | 110,803 | ||||||
Additional paid-in capital |
786,759 | 762,170 | ||||||
Retained earnings |
1,029,318 | 798,388 | ||||||
Accumulated other comprehensive income |
33,640 | 19,074 | ||||||
Total shareholders equity |
1,961,208 | 1,690,435 | ||||||
Total liabilities and shareholders equity |
$ | 7,544,239 | $ | 7,028,800 | ||||
5
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | (As restated) | |||||||||||||||
REVENUE |
||||||||||||||||
Net earned premium |
$ | 1,204,941 | $ | 995,901 | $ | 421,050 | $ | 338,058 | ||||||||
Fee and commission income |
104,409 | 100,999 | 38,862 | 32,073 | ||||||||||||
Net investment income |
108,959 | 70,039 | 36,205 | 24,998 | ||||||||||||
Net realized investment gain (loss) |
(1,193 | ) | 2,038 | 304 | 38 | |||||||||||
Other operating income |
59,071 | 26,116 | 20,276 | 16,864 | ||||||||||||
Total revenue |
1,476,187 | 1,195,093 | 516,697 | 412,031 | ||||||||||||
EXPENSE |
||||||||||||||||
Loss and loss adjustment expense, net |
689,122 | 679,932 | 236,030 | 295,768 | ||||||||||||
Policy acquisition costs, net |
231,012 | 187,696 | 78,203 | 65,708 | ||||||||||||
Other operating expense |
156,279 | 137,077 | 59,277 | 41,206 | ||||||||||||
Interest expense |
7,912 | 5,848 | 3,475 | 2,070 | ||||||||||||
Total expense |
1,084,325 | 1,010,553 | 376,985 | 404,752 | ||||||||||||
Earnings from continuing operations
before income tax expense |
391,862 | 184,540 | 139,712 | 7,279 | ||||||||||||
Income tax expense on continuing operations |
130,319 | 59,091 | 46,455 | 574 | ||||||||||||
Earnings from continuing operations |
261,543 | 125,449 | 93,257 | 6,705 | ||||||||||||
Earnings from discontinued operations,
net of income tax expense |
| 707 | | 707 | ||||||||||||
Net earnings |
$ | 261,543 | $ | 126,156 | $ | 93,257 | $ | 7,412 | ||||||||
Basic earnings per share data: |
||||||||||||||||
Earnings from continuing operations |
$ | 2.35 | $ | 1.20 | $ | 0.84 | $ | 0.06 | ||||||||
Earnings from discontinued operations |
| 0.01 | | 0.01 | ||||||||||||
Net earnings per share |
$ | 2.35 | $ | 1.21 | $ | 0.84 | $ | 0.07 | ||||||||
Weighted average shares outstanding |
111,198 | 104,617 | 111,359 | 105,623 | ||||||||||||
Diluted earnings per share data: |
||||||||||||||||
Earnings from continuing operations |
$ | 2.24 | $ | 1.16 | $ | 0.80 | $ | 0.06 | ||||||||
Earnings from discontinued operations |
| 0.01 | | 0.01 | ||||||||||||
Net earnings per share |
$ | 2.24 | $ | 1.17 | $ | 0.80 | $ | 0.07 | ||||||||
Weighted average shares outstanding |
116,986 | 108,003 | 117,003 | 109,818 | ||||||||||||
Cash dividends declared, per share |
$ | 0.275 | $ | 0.207 | $ | 0.100 | $ | 0.075 | ||||||||
6
Accumulated | ||||||||||||||||||||
Additional | other | Total | ||||||||||||||||||
Common | paid-in | Retained | comprehensive | shareholders' | ||||||||||||||||
stock | capital | earnings | income | equity | ||||||||||||||||
Balance at December 31, 2005 |
$ | 110,803 | $ | 762,170 | $ | 798,388 | $ | 19,074 | $ | 1,690,435 | ||||||||||
Net earnings |
| | 261,543 | | 261,543 | |||||||||||||||
Other comprehensive income |
| | | 14,566 | 14,566 | |||||||||||||||
Comprehensive income |
| | | | 276,109 | |||||||||||||||
Issuance of 688 shares for exercise of
options, including tax benefit of $3,291 |
688 | 14,285 | | | 14,973 | |||||||||||||||
Stock-based compensation |
| 10,304 | | | 10,304 | |||||||||||||||
Cash dividends declared, $0.275 per share |
| | (30,613 | ) | | (30,613 | ) | |||||||||||||
Balance at September 30, 2006 |
$ | 111,491 | $ | 786,759 | $ | 1,029,318 | $ | 33,640 | $ | 1,961,208 | ||||||||||
7
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | (As restated) | |||||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net earnings |
$ | 261,543 | $ | 126,156 | $ | 93,257 | $ | 7,412 | ||||||||
Adjustments to reconcile net earnings to
net cash provided by operating activities: |
||||||||||||||||
Change in premium, claims and other
receivables |
36,626 | (74,007 | ) | 46,924 | 16,604 | |||||||||||
Change in reinsurance recoverables |
56,031 | (145,305 | ) | 47,336 | (126,291 | ) | ||||||||||
Change in ceded unearned premium |
(4,587 | ) | 60,509 | (5,722 | ) | 14,648 | ||||||||||
Change in loss and loss adjustment
expense payable |
93,906 | 521,365 | (10,815 | ) | 396,478 | |||||||||||
Change in reinsurance balances payable |
(37,509 | ) | (23,906 | ) | (14,803 | ) | 15,744 | |||||||||
Change in unearned premium |
113,638 | 42,994 | 10,559 | 17,458 | ||||||||||||
Change in premium and claims payable,
net of restricted cash |
(78,293 | ) | 30,585 | (61,071 | ) | 15,049 | ||||||||||
Change in trading portfolio |
(99,193 | ) | (54,654 | ) | (14,702 | ) | (16,600 | ) | ||||||||
Depreciation and amortization expense |
12,242 | 11,063 | 4,598 | 3,703 | ||||||||||||
Stock-based compensation expense |
9,463 | 1,920 | 3,373 | 750 | ||||||||||||
Other, net |
(4,161 | ) | (43,466 | ) | 831 | (10,538 | ) | |||||||||
Cash provided by operating activities |
359,706 | 453,254 | 99,765 | 334,417 | ||||||||||||
Cash flows from investing activities: |
||||||||||||||||
Sales of fixed income securities |
184,175 | 163,841 | 20,078 | 49,071 | ||||||||||||
Maturity or call of fixed income securities |
174,758 | 133,391 | 57,060 | 34,923 | ||||||||||||
Cost of securities acquired |
(958,822 | ) | (733,400 | ) | (167,437 | ) | (235,256 | ) | ||||||||
Change in short-term investments |
171,198 | 36,234 | (47,658 | ) | (145,482 | ) | ||||||||||
Sale of strategic investment |
40,354 | 7,758 | 22,991 | 7,758 | ||||||||||||
Payments for purchase of subsidiaries, net
of cash received |
(55,290 | ) | (44,288 | ) | (17,833 | ) | (9,407 | ) | ||||||||
Sale of subsidiary |
| 10,448 | | 10,448 | ||||||||||||
Other, net |
(8,612 | ) | (14,627 | ) | (3,515 | ) | (3,249 | ) | ||||||||
Cash used by investing activities |
(452,239 | ) | (440,643 | ) | (136,314 | ) | (291,194 | ) | ||||||||
Cash flows from financing activities: |
||||||||||||||||
Issuance of notes payable |
140,000 | 36,000 | 101,000 | 3,000 | ||||||||||||
Payments on notes payable |
(56,346 | ) | (37,554 | ) | (45,097 | ) | (23,089 | ) | ||||||||
Sale of common stock |
14,973 | 32,684 | 5,313 | 3,847 | ||||||||||||
Dividends paid |
(27,774 | ) | (19,606 | ) | (11,126 | ) | (7,890 | ) | ||||||||
Other |
7,383 | (3,814 | ) | 1,755 | | |||||||||||
Cash provided (used) by financing
activities |
78,236 | 7,710 | 51,845 | (24,132 | ) | |||||||||||
Net increase (decrease) in cash |
(14,297 | ) | 20,321 | 15,296 | 19,091 | |||||||||||
Cash at beginning of period |
73,935 | 69,933 | 44,342 | 71,163 | ||||||||||||
Cash at end of period |
$ | 59,638 | $ | 90,254 | $ | 59,638 | $ | 90,254 | ||||||||
8
(1) | GENERAL INFORMATION | |
HCC Insurance Holdings, Inc. and its subsidiaries (collectively, we, us or our) include domestic and foreign property and casualty and life insurance companies, underwriting agencies and reinsurance brokers. We provide specialized property and casualty, surety, and group life, accident and health insurance coverages and related agency and reinsurance brokerage services to commercial customers and individuals. We market our products both directly to customers and through a network of independent brokers, producers and agents. Our lines of business include diversified financial products (which includes directors and officers liability, professional indemnity, employment practices liability and surety); group life, accident and health; aviation; London market account (which includes energy, marine, property, and accident and health); and other specialty lines of insurance. We operate primarily in the United States, the United Kingdom, Spain and Bermuda, although some of our operations have a broader international scope. | ||
Basis of Presentation | ||
Our unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (generally accepted accounting principles) and include the accounts of HCC Insurance Holdings, Inc. and its subsidiaries. We have made all adjustments that, in our opinion, are necessary for a fair presentation of results of the interim periods, and all such adjustments are of a normal recurring nature. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements should be read in conjunction with our annual audited consolidated financial statements and related notes. The condensed consolidated balance sheet at December 31, 2005 was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles. | ||
Management must make estimates and assumptions that affect amounts reported in our financial statements and in disclosures of contingent assets and liabilities. Ultimate results could differ from those estimates. We have reclassified certain amounts in our 2005 condensed consolidated financial statements to conform to the 2006 presentation. The reclassifications included the elimination of certain intercompany premium receivable and premium payable balances and reclassification of the corresponding lines in our 2005 condensed statements of cash flows. None of these reclassifications had an effect on our consolidated net earnings, shareholders equity or cash flows. | ||
During 2006 and 2005, we completed several acquisitions. The results of operations of the acquired entities are included in our condensed consolidated financial statements beginning on the effective date of each acquisition. Thus, our condensed consolidated statements of earnings and cash flows for the nine months and three months ended September 30, 2006 and 2005 do not contain any operations of the entities acquired in 2006 or 2005 prior to their acquisition date. | ||
Large Loss Events | ||
During the third quarter of 2005, catastrophic events occurred related to two major hurricanes, Katrina and Rita, and two minor ones (collectively, the 2005 hurricanes). We recognized a pre-tax loss, after reinsurance, of $74.4 million in our insurance company segment in that quarter with respect to the 2005 hurricanes. This loss included $53.7 million recorded in loss and loss adjustment expense and $20.7 million for premiums to reinstate our excess of loss reinsurance protection, which reduced net earned premium. Net earnings were reduced $48.3 million, or $0.45 per diluted share. |
9
Also during the third quarter of 2005, we reached agreements with various reinsurers to commute certain reinsurance recoverables related to our discontinued accident and health line of business. The reinsurers paid us $119.6 million of cash, which was less than the related recoverables, in consideration for discounting the recoverables and reassuming the associated loss reserves. We recorded a pre-tax loss of $26.0 million, which was included in loss and loss adjustment expense in our insurance company segment. Net earnings were reduced $16.9 million, or $0.16 per diluted share. | ||
Income Tax | ||
For the nine months ended September 30, 2006 and 2005, the income tax provision was calculated based on an estimated effective tax rate for each fiscal year. Our effective tax rate differs from the United States Federal statutory rate primarily due to tax-exempt municipal bond interest, state income taxes and a special $2.1 million U.S. repatriation tax benefit in 2005. | ||
Recent Accounting Change | ||
The Financial Accounting Standards Board (FASB) has issued FASB Interpretation (FIN) No. 48, Accounting for Uncertainty in Income Taxes. Effective January 1, 2007, FIN 48 clarifies the accounting for uncertain income tax positions. We are currently reviewing the requirements of FIN 48 to determine the effect it will have on our consolidated financial statements. | ||
The FASB issued SFAS No. 157, Fair Value Measurements (SFAS 157), which clarified the definition of fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurement. SFAS 157 does not require any new fair value measurements and eliminates inconsistencies in guidance found in various prior accounting pronouncements. SFAS 157 will be effective for us on January 1, 2008. We are currently assessing whether the adoption of SFAS 157 will have an impact on our consolidated financial statements. | ||
The Securities and Exchange Commission has issued Staff Accounting Bulletin (SAB) No.108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements. SAB 108 establishes a standard approach for quantifying the materiality of errors to current and prior period financial statements. SAB 108s guidelines must be applied in the fourth quarter, and adjustments, if any, will be recorded either by restating prior year financial statements or recording a cumulative effect adjustment as of January 1, 2006. We believe the requirements of SAB 108 will have no effect on our consolidated financial statements. |
10
(2) | RESTATEMENT OF FINANCIAL STATEMENTS | |
In light of published reports concerning the pricing of stock options and the timing of stock option grants at numerous other companies, in the second quarter of 2006 we undertook a voluntary internal review of our past practices related to grants of stock options. The voluntary review by our management concluded that the actual accounting measurement dates for certain past stock option grants differed from the originally stated grant dates, which were also utilized as the measurement dates for such awards. In August 2006, our Board of Directors formed a Special Committee of independent directors to commence an investigation of our past stock option granting practices for the period 1995 through 2005. The Special Committee was composed of the members of the Audit Committee of the Board of Directors. The Special Committee retained the law firm of Skadden, Arps, Slate, Meagher & Flom, LLP as its independent legal counsel and LECG as forensic accountants to aid in the investigation. | ||
On November 17, 2006, we announced that the Special Committee had made certain determinations as a result of its review of our past stock option granting practices. The Special Committee found that we had used incorrect accounting measurement dates for stock option grants covering a significant number of employees and members of our Board of Directors during the period 1997 through 2005 and that certain option grants were retroactively priced. Additionally, at the direction of the Special Committee, we reviewed our stock option granting practices from 1992, the year of our initial public stock offering, through 1994 and in 2006 and found incorrect measurement dates due to retroactive pricing were used in 2006. In substantially all of these instances, the price on the actual measurement date was higher than the price on the stated grant date; thus recipients of the options could exercise at a strike price lower than the actual measurement date price. To determine the actual measurement dates, the Special Committee utilized the following sources of information: |
| The dates on documentation such as e-mails, regulatory form filings, acquisition agreements and other correspondence; | ||
| The date that the relevant stock option grant was entered into Equity Edge, our stock option tracking and accounting system; | ||
| Requirements of Accounting Principles Board (APB) No. 25, Accounting for Stock Issued to Employees, and related interpretations; and | ||
| Guidance from the Office of Chief Accountant of the Securities and Exchange Commission (SEC) contained in a letter dated September 19, 2006. |
11
The Special Committee concluded that mis-priced option grants, the effect of which, together with certain other adjustments, resulted in a cumulative net decrease in shareholders equity at December 31, 2005 of $3.3 million, affected all levels of employees. The Special Committee found that Stephen L. Way, Chief Executive Officer, retroactively priced options, that he should have known he was granting options in a manner that conflicted with our stock option plans and public statements, and that this constituted a failure to align the stock option granting process with our stock option plans and public statements. Although finding his actions were inconsistent with the duties and obligations of a chief executive officer of a publicly-traded company, the Special Committee also found that Mr. Ways motivation appeared to be the attraction and retention of talent and to provide employees with the best option price. The Special Committee also concluded that Christopher L. Martin, Executive Vice President and General Counsel, was aware that options were being retroactively priced in a manner inconsistent with applicable plan terms and the procedures memoranda that he had prepared, that granting in-the-money options had accounting implications, and that he did not properly document our Compensation Committees informal delegation of authority to Mr. Way. The Special Committee also found that there was no evidence that Mr. Way or Mr. Martin intended to falsify the consolidated financial statements. | ||
Before the Board of Directors reviewed the results of the investigation, the Chairman of the Compensation Committee tendered his resignation from the Board of Directors on November 8, 2006. After reviewing the results of the investigation, the Board of Directors determined that it would be appropriate to accept the resignations of Mr. Way and Mr. Martin, which both tendered on November 17, 2006. Mr. Way will remain a director of HCC and serve as the non-executive Chairman of the Board of Directors and has entered into a consulting agreement with us to assist in the transition of leadership and to provide strategic guidance. We have entered into agreements with Mr. Way and Mr. Martin which, among other things, require them to disgorge an amount equal to the difference between the actual measurement date prices determined by HCC and the prices at which these individuals exercised mis-priced options since 1997. | ||
As a result of the determinations of the Special Committee and because the resulting cumulative charge would be material to the second quarter and full year 2006 consolidated net earnings, we concluded that we needed to amend our 2005 Annual Report filed with the SEC on Form 10-K and our first quarter 2006 quarterly report filed with the SEC on Form 10-Q, to restate our consolidated financial statements and disclosures. However, the impact of the restatement in any of the restated periods is not material. The amended Forms 10-K/A and 10-Q/A have been filed with the SEC. We made the restatement in accordance with generally accepted accounting principles to record the following: |
| Non-cash compensation expense for the difference between the stock price on the stated grant date and the actual measurement date and for the fluctuations in stock price in certain instances where variable accounting should have been applied. | ||
| Other adjustments that were not recorded in the originally filed financial statements due to their immateriality. These minor adjustments primarily relate to fee and commission income, loss and loss adjustment expense, policy acquisition costs and other operating expense. In addition, balance sheet reclassifications have been recorded to appropriately present certain reinsurance recoverables and payables. | ||
| Related tax effects associated with the recognition of non-cash compensation expense and other adjustments as well as additional taxes that may be due and payable. |
We have not amended any of our other previously filed annual reports on Form 10-K or quarterly reports on Form 10-Q for the periods affected by the restatement other than noted above. For this reason, the consolidated financial statements and related financial information contained in such previously filed reports should no longer be relied upon. |
12
We were unable to timely file our quarterly reports on Form 10-Q for the quarters ended June 30, 2006 and September 30, 2006, primarily due to not knowing the financial impact of the Special Committees investigation. We have also restated the June 30, 2005 and September 30, 2005 financial statements included in our quarterly reports on Form 10-Q for the respective 2006 quarters. | ||
Based on the determinations of the Special Committee and our voluntary internal review, we identified a number of occasions during the period 1997 through 2005 and into 2006 on which we used an incorrect measurement date for financial accounting and reporting purposes for options granted. In accordance with Accounting Principles Board (APB) No. 25, Accounting for Stock Issued to Employees, and its related interpretations, we should have recorded compensation expense related to these options for the excess of the market price of our stock on the actual measurement date over the exercise price of the option. For periods commencing January 1, 2006, compensation expense is being recognized in accordance with Statement of Financial Accounting Standards (SFAS) No. 123(R) (revised), Share-Based Payment. However, we determined an incremental amount related to the mis-priced options must be recorded. | ||
The types of errors identified were as follows: |
| We determined that many block grants to employees during the period 1997 through 2005 were subject to a retroactive look-back period. In all such cases, the price of our stock at the end of the look-back period, which was generally 30 days or less, was higher than the price of our stock on the stated grant date. | ||
| In addition to being subject to the retroactive pricing discussed above, we determined that the strike price of block grants in 1999, 2002 and 2005 was determined prior to the final determination of the identity of the employee and/or the number of options to be granted. Further, proper approval, in most cases, had not been given until after the grant date. In all such cases, the price of our stock at the time when all required determinations were final and proper approval had been obtained was higher than the price of our stock on the stated grant date. The time lag between the stated grant date and the finalization of the awards was typically 30-45 days, except in the case of the 2002 grant which was finalized several months subsequent to the stated grant date. | ||
| For the period from 1997 to 2005 and into 2006, we determined that there was a regular practice of granting options to newly hired employees and existing employees being promoted after the end of a 30-45 day period following the hire or promotion date. This practice included the use of the 30-45 day period as a look-back period during which the date with the lowest price during that period was selected as the stated grant date. | ||
| In several instances, grants to senior executives were determined at a date subsequent to the stated grant date. In most cases, this resulted from extended negotiations of employment agreements and, in some cases, administrative delays. In virtually all cases, the price of our stock at the time the grants were made and properly approved was higher than the price of our stock on the stated grant date. | ||
| In a few cases, options were granted and then repriced downward. As a result, variable accounting should have been applied to these options. | ||
| We lacked timely or adequate documentation to support the stated grant date in the case of certain of the above errors. |
The gross compensation expense recorded to correct the above errors was a non-cash charge and had no impact on our reported net revenue, cash, cash flow or shareholders equity. |
13
In connection with the investigation, we determined that a number of executive officers received in-the-money options. If such options are ultimately determined to be in-the-money grants for tax purposes, pursuant to Section 162(m) of the Internal Revenue Code and, if in the year of exercise the officers compensation, including proceeds from options exercised, exceeded $1.0 million, we would not be entitled to a tax deduction for any amount in excess of such $1.0 million for officers covered by Section 162(m). We estimate the tax effect of the deduction was $4.6 million, substantially all of which was recorded as a reduction to shareholders equity. | ||
There were immaterial adjustments that were not made in the originally filed consolidated financial statements. We have taken the opportunity presented by this restatement to record these adjustments, which amounted to a net $2.4 million increase in earnings from continuing operations before income tax expense, for the years 2001 through 2005. | ||
The increase (decrease) on net earnings of each type of adjustment was as follows (in thousands): |
Non-cash | ||||||||||||||||||||||||
Net earnings | stock option | |||||||||||||||||||||||
as previously | compensation | Total | Net earnings | |||||||||||||||||||||
reported | expense | Other | Tax effect | adjustments | as restated | |||||||||||||||||||
Nine months ended September 30, 2005 |
$ | 129,326 | $ | (2,193 | ) | $ | (2,453 | ) | $ | 1,476 | $ | (3,170 | ) | $ | 126,156 | |||||||||
Three months ended September 30, 2005 |
$ | 7,950 | $ | (803 | ) | $ | | $ | 265 | $ | (538 | ) | $ | 7,412 |
The restatement adjustments reduced previously reported diluted net earnings per share by $0.03 and $0.00 for the nine and three months ended September 30, 2005, respectively. | ||
Enacted October 22, 2004, Section 409A of the Internal Revenue Code significantly changed the rules for nonqualified deferred compensation plans. Section 409A imposes certain restrictions and taxes on stock awards that constitute deferred compensation. Section 409A relates specifically to the personal tax liabilities of our employees that have received discounted options. We are currently reviewing the implications of Section 409A on grants awarded with intrinsic value that vested after December 31, 2004 and modifications made to existing grants after October 3, 2004 along with potential remedial actions. | ||
As of December 15, 2006, we have paid direct costs of approximately $6.0 million, of which $2.5 million was incurred through September 30, 2006, for costs associated with the Special Committees investigation and additional related professional services and consulting fees associated with the restatement effort. |
14
The following table sets forth the impact of the above adjustments and the related tax effects on our historical statements of earnings for the nine and three months ended September 30, 2005. |
Nine Months ended September 30, 2005 | Three Months ended September 30, 2005 | |||||||||||||||||||||||
As previously | As previously | |||||||||||||||||||||||
reported | Adjustments | As restated | reported | Adjustments | As restated | |||||||||||||||||||
REVENUE |
||||||||||||||||||||||||
Net earned premium |
$ | 995,901 | $ | | $ | 995,901 | $ | 338,058 | $ | | $ | 338,058 | ||||||||||||
Fee and commission income |
102,452 | (1,453 | ) | 100,999 | 32,073 | | 32,073 | |||||||||||||||||
Net investment income |
70,039 | | 70,039 | 24,998 | | 24,998 | ||||||||||||||||||
Net realized investment gain |
2,038 | | 2,038 | 38 | | 38 | ||||||||||||||||||
Other operating income |
26,116 | | 26,116 | 16,864 | | 16,864 | ||||||||||||||||||
Total revenue |
1,196,546 | (1,453 | ) | 1,195,093 | 412,031 | | 412,031 | |||||||||||||||||
EXPENSE |
||||||||||||||||||||||||
Loss and loss adjustment
expense, net |
679,932 | | 679,932 | 295,768 | | 295,768 | ||||||||||||||||||
Policy acquisition costs, net |
185,696 | 2,000 | 187,696 | 65,708 | | 65,708 | ||||||||||||||||||
Other operating expense |
135,884 | 1,193 | 137,077 | 40,403 | 803 | 41,206 | ||||||||||||||||||
Interest expense |
5,848 | | 5,848 | 2,070 | | 2,070 | ||||||||||||||||||
Total expense |
1,007,360 | 3,193 | 1,010,553 | 403,949 | 803 | 404,752 | ||||||||||||||||||
Earnings from continuing
operations
before income tax expense |
189,186 | (4,646 | ) | 184,540 | 8,082 | (803 | ) | 7,279 | ||||||||||||||||
Income tax expense on
continuing
operations |
60,567 | (1,476 | ) | 59,091 | 839 | (265 | ) | 574 | ||||||||||||||||
Earnings from continuing
operations |
128,619 | (3,170 | ) | 125,449 | 7,243 | (538 | ) | 6,705 | ||||||||||||||||
Earnings from discontinued
operations,
net of income taxes |
707 | | 707 | 707 | | 707 | ||||||||||||||||||
Net earnings |
$ | 129,326 | $ | (3,170 | ) | $ | 126,156 | $ | 7,950 | $ | (538 | ) | $ | 7,412 | ||||||||||
Basic earnings per share data: |
||||||||||||||||||||||||
Earnings from continuing operations |
$ | 1.23 | $ | (0.03 | ) | $ | 1.20 | $ | 0.07 | $ | (0.01 | ) | $ | 0.06 | ||||||||||
Earnings from discontinued
operations |
0.01 | | 0.01 | 0.01 | | 0.01 | ||||||||||||||||||
Net earnings |
$ | 1.24 | $ | (0.03 | ) | $ | 1.21 | $ | 0.08 | $ | (0.01 | ) | $ | 0.07 | ||||||||||
Weighted average shares outstanding |
104,617 | | 104,617 | 105,623 | | 105,623 | ||||||||||||||||||
Diluted earnings per share data: |
||||||||||||||||||||||||
Earnings from continuing operations |
$ | 1.19 | $ | (0.03 | ) | $ | 1.16 | $ | 0.06 | $ | | $ | 0.06 | |||||||||||
Earnings from discontinued
operations |
0.01 | | 0.01 | 0.01 | | 0.01 | ||||||||||||||||||
Net earnings |
$ | 1.20 | $ | (0.03 | ) | $ | 1.17 | $ | 0.07 | $ | | $ | 0.07 | |||||||||||
Weighted average shares outstanding |
108,003 | | 108,003 | 109,818 | | 109,818 | ||||||||||||||||||
15
The restatement did not impact our net cash flows from operating, investing, or financing activities. However, certain items within net cash provided by operating activities were affected by the restatement adjustments. The following table shows the effect of the restatement on our previously reported cash flows: |
Nine months ended | Three months ended | |||||||||||||||
September 30, 2005 | September 30, 2005 | |||||||||||||||
As previously | As previously | |||||||||||||||
reported | As restated | reported | As restated | |||||||||||||
Net earnings |
$ | 129,326 | $ | 126,156 | $ | 7,950 | $ | 7,412 | ||||||||
Adjustments to reconcile net earnings
to net cash provided by operating activities: |
||||||||||||||||
Change in premium, claims and other
receivables |
(37,538 | ) | (74,007 | ) | 39,121 | 16,604 | ||||||||||
Change in reinsurance recoverables |
(156,477 | ) | (145,305 | ) | (138,947 | ) | (126,291 | ) | ||||||||
Change in ceded unearned premium |
65,591 | 60,509 | 14,648 | 14,648 | ||||||||||||
Change in reinsurance balances payable |
(34,966 | ) | (23,906 | ) | 15,744 | 15,744 | ||||||||||
Change in premium and claims payable, net of restricted cash |
3,728 | 30,585 | 5,188 | 15,049 | ||||||||||||
Stock-based compensation expense |
| 1,920 | | 750 | ||||||||||||
Other, net |
(37,178 | ) | (43,466 | ) | (10,326 | ) | (10,538 | ) |
Nine months ended | Three months ended | |||||||||||||||
September 30, 2005 | September 30, 2005 | |||||||||||||||
As previously | As previously | |||||||||||||||
reported | As restated | reported | As restated | |||||||||||||
Reported net earnings |
$ | 129,326 | $ | 126,156 | $ | 7,950 | $ | 7,412 | ||||||||
Stock-based compensation included
in reported net earnings,
net of income taxes |
| 1,576 | | 538 | ||||||||||||
Stock-based compensation using fair
value
method, net of income taxes |
(4,617 | ) | (5,585 | ) | (1,927 | ) | (2,247 | ) | ||||||||
Pro forma net earnings |
$ | 124,709 | $ | 122,147 | $ | 6,023 | $ | 5,703 | ||||||||
Reported basic earnings per share |
$ | 1.24 | $ | 1.21 | $ | 0.08 | $ | 0.07 | ||||||||
Fair value stock-based compensation |
(0.05 | ) | (0.04 | ) | (0.02 | ) | (0.02 | ) | ||||||||
Pro forma basic earnings per share |
$ | 1.19 | $ | 1.17 | $ | 0.06 | $ | 0.05 | ||||||||
Reported diluted earnings per share |
$ | 1.20 | $ | 1.17 | $ | 0.07 | $ | 0.07 | ||||||||
Fair value stock-based compensation |
(0.05 | ) | (0.04 | ) | (0.02 | ) | (0.02 | ) | ||||||||
Pro forma diluted earnings per share |
$ | 1.15 | $ | 1.13 | $ | 0.05 | $ | 0.05 | ||||||||
16
(3) | STOCK OPTIONS | |
Our stock option plans, the 2004 Flexible Incentive Plan and 2001 Flexible Incentive Plan, are administered by the Compensation Committee of the Board of Directors. Options granted under these plans may be used to purchase one share of our common stock. The plans require that all options be granted at fixed exercise prices at the market price of our common stock on the grant date and do not allow repricing of options. Options vest over a period of up to seven years, which is the requisite service period, and expire four to ten years after grant date. | ||
Statement of Financial Accounting Standards (SFAS) No. 123(R), Share-Based Payment, requires companies to charge the fair value of stock-based compensation to earnings. Effective January 1, 2006, we adopted SFAS 123(R) using the modified prospective method. We are recognizing compensation expense in 2006 and thereafter based on our unvested stock options granted before January 1, 2006 and all options granted after that date. We use the Black-Scholes single option pricing model to determine the fair value of an option on its grant date and expense that value on a straight-line basis over the options vesting period. We made no modifications to our stock option plans in conjunction with our adoption of SFAS 123(R). In 2005, we accounted for stock options granted to employees in accordance with Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees. The 2005 and prior period financial statements were not restated to reflect the implementation of SFAS 123(R). | ||
In the first nine months of 2006, we expensed $9.5 million ($6.8 million after-tax or $0.06 per diluted share) of stock-based compensation, after the effect of the deferral and amortization of related policy acquisition costs. We expensed $3.4 million ($2.4 million after-tax or $0.02 per diluted share) in the third quarter of 2006. At September 30, 2006, there was approximately $33.0 million of total unrecognized compensation expense related to unvested options that is expected to be recognized over a weighted-average period of three years. In 2006, we expect to recognize $12.9 million of expense, including the amortization of deferred policy acquisition costs, related to stock-based compensation for options currently outstanding. |
17
The table below shows the weighted-average fair value of options granted and the related weighted-average assumptions used in the Black-Scholes model. The risk-free interest rate is based on the U.S. Treasury rate that most closely approximates each options expected term. We based our expected volatility on the historical volatility of our stock over a period matching each options expected term. Our dividend yield is based on an average of our historical dividend payments divided by the stock price. We used historical exercise patterns by grant type to estimate the expected option life. |
Nine months ended September 30, | Three months ended September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | (As restated) | |||||||||||||||
Fair value of options granted |
$ | 7.05 | $ | 8.86 | $ | 6.74 | $ | 9.11 | ||||||||
Risk free interest rate |
4.7 | % | 4.0 | % | 5.1 | % | 4.1 | % | ||||||||
Expected volatility |
21.9 | % | 32.0 | % | 21.4 | % | 32.0 | % | ||||||||
Expected dividend yield |
1.1 | % | 1.1 | % | 1.3 | % | 1.2 | % | ||||||||
Expected option life |
3.7 years | 4.8 years | 4.1 years | 4.8 years |
The following table details our stock option activity during the nine months ended September 30, 2006. |
Weighted- | Weighted- | |||||||||||||||
average | average | Aggregate | ||||||||||||||
Number | exercise | contractual | intrinsic | |||||||||||||
of shares | price | life | value | |||||||||||||
Outstanding, beginning of year |
8,219 | $ | 20.71 | |||||||||||||
Granted |
748 | 31.66 | ||||||||||||||
Exercised |
(690 | ) | 16.97 | |||||||||||||
Forfeited and expired |
(145 | ) | 20.89 | |||||||||||||
Outstanding, end of period |
8,132 | 22.03 | 3.9 years | $ | 88,305 | |||||||||||
Exercisable, end of period |
2,458 | 19.55 | 3.1 years | 32,750 | ||||||||||||
The aggregate intrinsic value (the amount by which the fair value of the underlying stock exceeds the exercise price) of options exercised during the first nine months of 2006 and 2005 was $10.4 million and $21.9 million, respectively. At September 30, 2006, 11.8 million shares of our common stock were authorized and reserved for the exercise of options, of which 8.1 million shares were reserved for options previously granted and 3.7 million shares were reserved for future issuance. |
18
Exercise of options during the first nine months of 2006 and 2005 resulted in cash receipts of $11.7 million and $32.7 million, respectively. We generally recognize a tax benefit when our employees exercise options. SFAS 123(R) requires that we report the tax benefit related to the excess of the tax deductible amount over the recognized compensation expense as financing cash flow, rather than as operating cash flow under APB 25. We recorded a $3.3 million benefit as financing cash flow in the first nine months of 2006 and $3.4 million as operating cash flow in the first nine months of 2005. | ||
Prior to the adoption of SFAS 123(R), we accounted for stock-based compensation using the intrinsic value method prescribed in APB Opinion No. 25 and related interpretations. Under APB Opinion No. 25, compensation cost was measured as of the date the number of shares and exercise price became fixed. The terms of an award were generally fixed on the date of grant, requiring the stock option to be accounted for as a fixed award. For fixed awards, compensation expense was measured as the excess, if any, of the quoted market price of our stock at the date of grant over the exercise price of the option granted. Compensation expense for fixed awards, if any, was recognized ratably over the vesting period using the straight-line single option method. | ||
If the number of shares or exercise price was not fixed upon the date of grant, the award was accounted for as a variable award until the number of shares or the exercise price became fixed, or until the award was exercised, canceled, or expired unexercised. For variable awards, intrinsic value was remeasured each period and was equal to the fair market value of our stock as of the end of the reporting period less the grant exercise price. As a result, the amount of compensation expense or benefit to be recognized each period fluctuated based on changes in our closing price from the end of the previous reporting period to the end of the current reporting period. In cases when our closing stock price did not exceed the recipients exercise price, no compensation expense resulted. Compensation expense for variable awards, if any, was recognized in accordance with FIN No. 28, Accounting for Stock Appreciation Rights and Other Variable Stock Option or Award Plan, An Interpretation of APB Opinions No. 15 and 25. |
19
We accounted for modifications to stock options under APB No. 25, as subsequently interpreted by FIN No. 44. Modifications included, but were not limited to, acceleration of vesting, extension of the exercise period following termination of employment and/or continued vesting while not providing substantive services. Compensation expense for modified awards was recorded in the period of modification for the intrinsic value of the vested portion of the award, including vesting that occurred while not providing substantive services, after the date of modification. The intrinsic value of the award was the difference between the fair market value of our common stock on the date of modification and the recipients exercise price. | ||
Stock options issued to non-employees were accounted for in accordance with the provisions of SFAS No. 123 and EITF No. 96-18, Accounting for Equity Instruments That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services. Compensation expense for stock options issued to non-employees was valued using the Black-Scholes model and was amortized over the vesting period in accordance with FIN No. 28. | ||
Prior to adoption of SFAS 123(R), we were required to disclose the effect on net earnings and earnings per share if we had used the fair value method of SFAS No. 123, Accounting for Stock-Based Compensation, to value stock options. The effect on our consolidated financial results in 2005 if we had valued our options using the fair value method under SFAS 123 and the assumptions listed above is as follows: |
Nine months | Three months | |||||||
ended September 30, | ended September 30, | |||||||
2005 | 2005 | |||||||
(As restated) | (As restated) | |||||||
Reported net earnings |
$ | 126,156 | $ | 7,412 | ||||
Stock-based compensation included in reported net earnings,
net of income taxes |
1,576 | 538 | ||||||
Stock-based compensation using
fair value method, net of income taxes |
(5,585 | ) | (2,247 | ) | ||||
Pro forma net earnings |
$ | 122,147 | $ | 5,703 | ||||
Reported basic earnings per share |
$ | 1.21 | $ | 0.07 | ||||
Fair value stock-based compensation |
(0.04 | ) | (0.02 | ) | ||||
Pro forma basic earnings per share |
$ | 1.17 | $ | 0.05 | ||||
Reported diluted earnings per share |
$ | 1.17 | $ | 0.07 | ||||
Fair value stock-based compensation |
(0.04 | ) | (0.02 | ) | ||||
Pro forma diluted earnings per share |
$ | 1.13 | $ | 0.05 | ||||
20
(4) | REINSURANCE | |
In the normal course of business, our insurance companies cede a portion of their premium to domestic and foreign reinsurers through treaty and facultative reinsurance agreements. Although ceding for reinsurance purposes does not discharge the primary insurer from liability to its policyholder, our insurance companies participate in such agreements in order to limit their loss exposure, protect them against catastrophic loss and diversify their business. The following table presents the effect of such reinsurance transactions on our premium and loss and loss adjustment expense. |
Loss and loss | ||||||||||||
Written | Earned | adjustment | ||||||||||
premium | premium | expense | ||||||||||
(As restated) | ||||||||||||
Nine months ended September 30, 2006 |
||||||||||||
Primary business |
$ | 1,399,831 | $ | 1,326,392 | $ | 756,316 | ||||||
Reinsurance assumed |
228,382 | 205,139 | 112,321 | |||||||||
Reinsurance ceded |
(329,099 | ) | (326,590 | ) | (179,515 | ) | ||||||
Net amounts |
$ | 1,299,114 | $ | 1,204,941 | $ | 689,122 | ||||||
Nine months ended September 30, 2005 |
||||||||||||
Primary business |
$ | 1,322,105 | $ | 1,260,309 | $ | 977,749 | ||||||
Reinsurance assumed |
217,897 | 225,010 | 202,306 | |||||||||
Reinsurance ceded |
(432,559 | ) | (489,418 | ) | (500,123 | ) | ||||||
Net amounts |
$ | 1,107,443 | $ | 995,901 | $ | 679,932 | ||||||
Three months ended September 30, 2006 |
||||||||||||
Primary business |
$ | 467,499 | $ | 459,826 | $ | 280,133 | ||||||
Reinsurance assumed |
68,602 | 69,543 | 29,198 | |||||||||
Reinsurance ceded |
(113,520 | ) | (108,319 | ) | (73,301 | ) | ||||||
Net amounts |
$ | 422,581 | $ | 421,050 | $ | 236,030 | ||||||
Three months ended September 30, 2005 |
||||||||||||
Primary business |
$ | 458,029 | $ | 431,573 | $ | 513,382 | ||||||
Reinsurance assumed |
67,418 | 74,146 | 103,473 | |||||||||
Reinsurance ceded |
(153,749 | ) | (167,661 | ) | (321,087 | ) | ||||||
Net amounts |
$ | 371,698 | $ | 338,058 | $ | 295,768 | ||||||
21
Ceding commissions netted with policy acquisition costs in the condensed consolidated statements of earnings were $35.1 million in the first nine months of 2006 and $80.6 million in the first nine months of 2005. | ||
The table below shows the components of reinsurance recoverables in our condensed consolidated balance sheets. |
September 30, | December 31, | |||||||
2006 | 2005 | |||||||
(As restated) | ||||||||
Reinsurance recoverable on paid losses |
$ | 164,681 | $ | 93,837 | ||||
Reinsurance recoverable on outstanding losses |
615,486 | 636,225 | ||||||
Reinsurance recoverable on incurred but not reported losses |
540,178 | 644,062 | ||||||
Reserve for uncollectible reinsurance |
(14,393 | ) | (12,141 | ) | ||||
Total reinsurance recoverables |
$ | 1,305,952 | $ | 1,361,983 | ||||
Our reserve for uncollectible reinsurance covers potential collectibility issues, including disputed amounts and associated expenses. While we believe the reserve is adequate based on information currently available, conditions may change or additional information might be obtained which may require us to change the reserve in the future. We periodically review our financial exposure to the reinsurance market and the level of our reserve and continue to take actions in an attempt to mitigate our exposure to possible loss. | ||
We limit the liquidity exposure related to our reinsurance recoverables by holding funds, letters of credit or other security, such that net balances due are significantly less than the gross balances shown in our condensed consolidated balance sheets. Additionally, our U.S. domiciled insurance companies require their reinsurers not authorized by the respective states of domicile of our insurance companies to collateralize their reinsurance obligations due to us. The table below shows the amounts of letters of credit and cash deposits held by us as collateral, plus other credits available for potential offset. |
September 30, | December 31, | |||||||
2006 | 2005 | |||||||
Payables to reinsurers |
$ | 254,530 | $ | 291,826 | ||||
Letters of credit |
348,103 | 350,135 | ||||||
Cash deposits |
58,985 | 64,150 | ||||||
Total credits |
$ | 661,618 | $ | 706,111 | ||||
22
The tables below present the calculation of net reserves, net unearned premium and net deferred policy acquisition costs. |
September 30, | December 31, | |||||||
2006 | 2005 | |||||||
(As restated) | ||||||||
Loss and loss adjustment expense payable |
$ | 2,907,626 | $ | 2,813,720 | ||||
Reinsurance recoverable on outstanding losses |
(615,486 | ) | (636,225 | ) | ||||
Reinsurance recoverable on incurred but not reported losses |
(540,178 | ) | (644,062 | ) | ||||
Net reserves |
$ | 1,751,962 | $ | 1,533,433 | ||||
Unearned premium |
$ | 924,518 | $ | 807,109 | ||||
Ceded unearned premium |
(244,003 | ) | (239,416 | ) | ||||
Net unearned premium |
$ | 680,515 | $ | 567,693 | ||||
Deferred policy acquisition costs |
$ | 181,111 | $ | 156,253 | ||||
Deferred ceding commissions |
(67,231 | ) | (67,886 | ) | ||||
Net deferred policy acquisition costs |
$ | 113,880 | $ | 88,367 | ||||
(5) | EARNINGS PER SHARE | |
The following table details the numerator and denominator used in the earnings per share calculations. |
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | (As restated) | |||||||||||||||
Net earnings |
$ | 261,543 | $ | 126,156 | $ | 93,257 | $ | 7,412 | ||||||||
Weighted average common shares
outstanding |
111,198 | 104,617 | 111,359 | 105,623 | ||||||||||||
Dilutive effect of outstanding options
(determined using the treasury stock
method) |
1,558 | 1,584 | 1,511 | 1,636 | ||||||||||||
Dilutive effect of convertible debt
(determined using the treasury stock
method) |
4,230 | 1,802 | 4,133 | 2,559 | ||||||||||||
Weighted average common shares and
potential common shares outstanding |
116,986 | 108,003 | 117,003 | 109,818 | ||||||||||||
Anti-dilutive stock options not included in
treasury stock method computation |
2,823 | 680 | 1,803 | 13 | ||||||||||||
23
(6) | SEGMENT AND GEOGRAPHIC INFORMATION | |
The performance of each segment is evaluated by our management based on net earnings. Net earnings is calculated after tax and after all corporate expense allocations, interest expense on debt incurred at the purchase date, and intercompany eliminations have been charged or credited to our individual segments. All stock-based compensation is included in the corporate segment since it is not included in managements evaluation of the other segments. The following tables show information by business segment and geographic location. Geographic location is determined by physical location of our offices and does not represent the location of insureds or reinsureds from whom the business was generated. Effective April 1, 2006 and January 1, 2005, we consolidated two underwriting agencies into two insurance companies and all operations after those dates have been reported in our insurance company segment. |
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Nine months ended
September 30, 2006 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 1,077,065 | $ | 49,256 | $ | 57,792 | $ | 4,413 | $ | 1,188,526 | ||||||||||
Foreign |
260,526 | 27,135 | | | 287,661 | |||||||||||||||
Inter-segment |
19 | 54,473 | | | 54,492 | |||||||||||||||
Total segment revenue |
$ | 1,337,610 | $ | 130,864 | $ | 57,792 | $ | 4,413 | 1,530,679 | |||||||||||
Inter-segment eliminations |
(54,492 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 1,476,187 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 159,617 | $ | 21,858 | $ | 37,336 | $ | (13,909 | ) | $ | 204,902 | |||||||||
Foreign |
48,625 | 6,939 | | | 55,564 | |||||||||||||||
Total segment net earnings (loss) |
$ | 208,242 | $ | 28,797 | $ | 37,336 | $ | (13,909 | ) | 260,466 | ||||||||||
Inter-segment eliminations |
1,077 | |||||||||||||||||||
Consolidated net earnings |
$ | 261,543 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 98,492 | $ | 6,916 | $ | 1,839 | $ | 1,712 | $ | 108,959 | ||||||||||
Depreciation and amortization |
3,425 | 6,792 | 381 | 1,644 | 12,242 | |||||||||||||||
Interest expense (benefit) |
838 | 8,875 | 423 | (2,224 | ) | 7,912 | ||||||||||||||
Capital expenditures |
2,837 | 1,629 | 498 | 4,681 | 9,645 | |||||||||||||||
Income tax expense (benefit) |
97,240 | 20,607 | 18,459 | (6,629 | ) | 129,677 | ||||||||||||||
Inter-segment eliminations |
642 | |||||||||||||||||||
Consolidated income tax expense |
$ | 130,319 | ||||||||||||||||||
24
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Nine months ended
September 30, 2005 (As restated) |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 891,726 | $ | 46,532 | $ | 22,067 | $ | 1,974 | $ | 962,299 | ||||||||||
Foreign |
203,278 | 29,516 | | | 232,794 | |||||||||||||||
Inter-segment |
153 | 65,789 | | | 65,942 | |||||||||||||||
Total segment revenue |
$ | 1,095,157 | $ | 141,837 | $ | 22,067 | $ | 1,974 | 1,261,035 | |||||||||||
Inter-segment eliminations |
(65,942 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 1,195,093 | ||||||||||||||||||
Net earnings: |
||||||||||||||||||||
Domestic |
$ | 75,805 | $ | 20,592 | $ | 13,716 | $ | (198 | ) | $ | 109,915 | |||||||||
Foreign |
9,466 | 4,245 | | | 13,711 | |||||||||||||||
Total segment net earnings |
$ | 85,271 | (1) | $ | 24,837 | $ | 13,716 | $ | (198 | ) | 123,626 | |||||||||
Inter-segment eliminations |
1,823 | |||||||||||||||||||
Earnings from discontinued
operations, net of income taxes |
707 | |||||||||||||||||||
Consolidated net earnings |
$ | 126,156 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 63,222 | $ | 4,820 | $ | 767 | $ | 1,230 | $ | 70,039 | ||||||||||
Depreciation and amortization |
3,500 | 5,603 | 343 | 1,617 | 11,063 | |||||||||||||||
Interest expense (benefit) |
313 | 6,859 | 564 | (1,888 | ) | 5,848 | ||||||||||||||
Capital expenditures |
1,520 | 2,745 | 249 | 2,038 | 6,552 | |||||||||||||||
Income tax expense |
33,681 | 17,950 | 6,524 | 9 | 58,164 | |||||||||||||||
Inter-segment eliminations |
927 | |||||||||||||||||||
Consolidated income tax expense
on continuing operations |
$ | 59,091 | ||||||||||||||||||
(1) | Includes $48.3 million after-tax loss due to the 2005 hurricanes and $16.9 million after-tax loss due to commutations. |
25
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended
September 30, 2006 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 373,463 | $ | 19,581 | $ | 18,898 | $ | 1,899 | $ | 413,841 | ||||||||||
Foreign |
95,527 | 7,329 | | | 102,856 | |||||||||||||||
Inter-segment |
6 | 17,304 | | | 17,310 | |||||||||||||||
Total segment revenue |
$ | 468,996 | $ | 44,214 | $ | 18,898 | $ | 1,899 | 534,007 | |||||||||||
Inter-segment eliminations |
(17,310 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 516,697 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 54,922 | $ | 8,485 | $ | 12,221 | $ | (7,865 | ) | $ | 67,763 | |||||||||
Foreign |
23,827 | 695 | | | 24,522 | |||||||||||||||
Total segment net earnings
(loss) |
$ | 78,749 | $ | 9,180 | $ | 12,221 | $ | (7,865 | ) | 92,285 | ||||||||||
Inter-segment eliminations |
972 | |||||||||||||||||||
Consolidated net earnings |
$ | 93,257 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income (loss) |
$ | 33,111 | $ | 2,340 | $ | (39 | ) | $ | 793 | $ | 36,205 | |||||||||
Depreciation and amortization |
1,154 | 2,755 | 127 | 562 | 4,598 | |||||||||||||||
Interest expense |
118 | 3,007 | 159 | 191 | 3,475 | |||||||||||||||
Capital expenditures |
1,658 | 440 | 3 | 1,414 | 3,515 | |||||||||||||||
Income tax expense (benefit) |
36,783 | 6,530 | 6,000 | (3,338 | ) | 45,975 | ||||||||||||||
Inter-segment eliminations |
480 | |||||||||||||||||||
Consolidated income tax
expense |
$ | 46,455 | ||||||||||||||||||
26
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended
September 30, 2005 (As restated) |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 312,271 | $ | 16,668 | $ | 15,682 | $ | 769 | $ | 345,390 | ||||||||||
Foreign |
58,253 | 8,388 | | | 66,641 | |||||||||||||||
Inter-segment |
12 | 21,065 | | | 21,077 | |||||||||||||||
Total segment revenue |
$ | 370,536 | $ | 46,121 | $ | 15,682 | $ | 769 | 433,108 | |||||||||||
Inter-segment eliminations |
(21,077 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 412,031 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 2,276 | $ | 4,049 | $ | 9,821 | $ | 3,056 | $ | 19,202 | ||||||||||
Foreign |
(13,162 | ) | 659 | | | (12,503 | ) | |||||||||||||
Total segment net earnings
(loss) |
$ | (10,886 | )(1) | $ | 4,708 | $ | 9,821 | $ | 3,056 | 6,699 | ||||||||||
Inter-segment eliminations |
6 | |||||||||||||||||||
Earnings from discontinued
operations, net of income taxes |
707 | |||||||||||||||||||
Consolidated net earnings |
$ | 7,412 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 22,607 | $ | 1,924 | $ | 79 | $ | 388 | $ | 24,998 | ||||||||||
Depreciation and amortization |
1,164 | 1,708 | 128 | 703 | 3,703 | |||||||||||||||
Interest expense (benefit) |
47 | 2,514 | 186 | (677 | ) | 2,070 | ||||||||||||||
Capital expenditures |
757 | 1,211 | 172 | 1,119 | 3,259 | |||||||||||||||
Income tax expense (benefit) |
(9,875 | ) | 3,937 | 5,174 | 1,477 | 713 | ||||||||||||||
Inter-segment eliminations |
(139 | ) | ||||||||||||||||||
Consolidated income tax expense
on continuing operations |
$ | 574 | ||||||||||||||||||
(1) | Includes $48.3 million after-tax loss due to the 2005 hurricanes and $16.9 million after-tax loss due to commutations. |
27
The following tables present selected revenue items by line of business. |
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | ||||||||||||||||
Diversified financial products |
$ | 538,063 | $ | 371,414 | $ | 189,744 | $ | 143,084 | ||||||||
Group life, accident and health |
385,257 | 380,681 | 129,234 | 125,079 | ||||||||||||
Aviation |
112,661 | 101,817 | 40,430 | 35,008 | ||||||||||||
London market account |
80,455 | 66,402 | 31,590 | 8,784 | ||||||||||||
Other specialty lines |
88,569 | 69,574 | 30,033 | 25,023 | ||||||||||||
Discontinued lines |
(64 | ) | 6,013 | 19 | 1,080 | |||||||||||
Net earned premium |
$ | 1,204,941 | $ | 995,901 | $ | 421,050 | $ | 338,058 | ||||||||
Property and casualty |
$ | 86,016 | $ | 85,684 | $ | 32,565 | $ | 26,813 | ||||||||
Accident and health |
18,393 | 15,315 | 6,297 | 5,260 | ||||||||||||
Fee and commission income |
$ | 104,409 | $ | 100,999 | $ | 38,862 | $ | 32,073 | ||||||||
(6) | SUPPLEMENTAL INFORMATION | |
Supplemental information was as follows. |
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | (As restated) | |||||||||||||||
Cash received from commutations |
$ | 12,750 | $ | 154,078 | $ | 12,750 | $ | 119,621 | ||||||||
Income taxes paid |
125,228 | 63,138 | 50,354 | 13,579 | ||||||||||||
Interest paid |
7,044 | 5,756 | 3,556 | 3,140 | ||||||||||||
Comprehensive income (loss) |
276,109 | 108,161 | 132,891 | (5,185 | ) |
28
(7) | COMMITMENTS AND CONTINGENCIES | |
Litigation | ||
We are party to lawsuits, arbitrations and other proceedings that arise in the normal course of our business. Many of such lawsuits, arbitrations and other proceedings involve claims under policies that we underwrite as an insurer or reinsurer, the liabilities for which, we believe, have been adequately included in our loss reserves. Also, from time to time, we are a party to lawsuits, arbitrations and other proceedings that relate to disputes over contractual relationships with third parties, or that involve alleged errors and omissions on the part of our subsidiaries. We have provided accruals for these items to the extent we deem the losses probable and reasonably estimable. | ||
We have been engaged in litigation initiated by the appointed liquidator of a former reinsurer concerning payments made to us prior to the date of appointment of the liquidator. The disputed payments, totaling $10.3 million, were made by the now insolvent reinsurer in connection with a commutation agreement. We reached an agreement in principle with the liquidator to resolve this matter and are in the process of finalizing the agreements. The expected resolution will not have a material effect on our consolidated financial position, results of operations or cash flows. | ||
In April 2006, we were named as a defendant in a complaint related to insurance marketing and producer compensation practices. The lawsuit was filed in Federal District Court in Georgia by a number of corporate plaintiffs against approximately 100 insurance entity defendants. The suit has been transferred to the multi-district litigation proceeding pending in the United States District Court for the District of New Jersey for coordinated or consolidated pre-trial proceedings with suits previously transferred that appear to the court to involve common questions of fact. The complaint alleges violations of Federal antitrust law, the Racketeering Influence and Corrupt Organization Act and various state anti-fraud laws. The lawsuit seeks unspecified damages. We are vigorously contesting this action. | ||
Although the ultimate outcome of the matters mentioned above cannot be determined at this time, based on present information, the availability of insurance coverage and advice received from our outside legal counsel, we believe the resolution of these matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. |
29
Indemnifications | ||
In conjunction with the sales of business assets and subsidiaries, we have provided indemnifications to the buyers. Certain indemnifications cover typical representations and warranties related to our responsibilities to perform under the sales contracts. We cannot quantify the maximum potential exposure covered by all of our indemnifications because the indemnifications cover a variety of matters, operations and scenarios. Certain of these indemnifications have no time limit. For those with a time limit, the longest such indemnification expires on December 31, 2009. | ||
We accrue a loss related to our indemnifications when a valid claim is made by a buyer and we believe we have potential exposure. We currently have several claims under indemnifications that cover certain net losses incurred in periods prior to our sale of certain subsidiaries. As of September 30, 2006, we have recorded a liability of $13.9 million and have provided $5.2 million of letters of credit to cover our obligations or anticipated payments under these indemnifications. | ||
Stock Option Investigation Matters | ||
Based on the Special Committees voluntary independent investigation of our past practices related to granting stock options, we determined that the price on the actual measurement date for a number of our stock option grants during the period 1997 through 2005 and into 2006 did not correspond to the price on the stated grant date and that certain option grants were retroactively repriced. The investigation was conducted with the help of a law firm that was not previously involved with our stock option plans and procedures. The SEC has commenced an informal inquiry. In connection with its inquiry, we received a document request from the SEC. We intend to fully cooperate with the informal inquiry. We are unable to predict the outcome of or the future costs related to the informal inquiry. | ||
(8) | SUBSEQUENT EVENTS | |
On October 30, 2006, we received a registered letter from U.S. Bank, as trustee for the holders of our 2.00% Convertible Notes due 2021, 1.30% Convertible Notes due 2023 and 2.00% Convertible Exchange Notes due 2021, stating that U.S. Bank, as trustee, had not received our consolidated financial statements for the quarter ended June 30, 2006. If we do not file our Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 with the SEC and deliver the report to the trustee within sixty days from the date notice was received from the trustee, such failure to file and deliver will be considered an Event of Default under the indenture governing the notes. If an Event of Default were to occur under the indentures for any series of the notes, the trustee or holders of at least 25% of the aggregate principal of such series then outstanding could declare all the unpaid principal on such series of notes then outstanding to be immediately due and payable. Likewise, we have not timely delivered our Form 10-Qs for the quarters ended June 30 and September 30, 2006 as required by the terms of our Revolving Loan Facility agreement. The banks that are a party to the agreement waived certain Defaults or Events of Default until January 31, 2007. In addition, our restatement of our prior year financial statements might be considered an Event of Default which has been waived until January 31, 2007. Our failure to comply with the covenants in the indentures for our convertible notes and our Revolving Loan Facility loan agreement in the future could have a material adverse effect on our stock price, business and financial condition if we would not have available funds at that time to repay any defaulted debt. A default and acceleration under the indentures for our convertible notes and loan agreement may also trigger cross-acceleration under our other debt instruments. | ||
In December 2006, our existing Revolving Loan Facility was increased by $100.0 million to $300.0 million. Pursuant to the terms of the agreement, the Company can borrow up to $25 million in addition to what is currently borrowed for working capital purposes. However, the full unfunded amount of the facility would be available to pay any potential convertible note conversion or put. |
30
On August 3, 2006, we reached an agreement to acquire the assets of the Health Products Division (the Division) of Allianz Life Insurance Company of North America for cash consideration of $140.0 million and to assume the Divisions outstanding loss reserves. The Divisions operations include medical stop loss insurance for self-insured corporations and groups; excess insurance for HMOs; provider excess insurance for integrated delivery systems; excess medical reinsurance to small and regional insurance carriers; and Life Trac, a network for providing organ and bone marrow transplants. The Division currently writes more than $300.0 million in annual gross premium. We plan to integrate the Divisions operations into HCC Life Insurance Company, within our insurance company segment. Internal funds were utilized to make the acquisition, which was consummated on October 2, 2006. |
31
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
32
| Non-cash compensation expense for the difference between the stock price on the stated grant date and the actual measurement date and for the fluctuations in stock price in certain instances where variable accounting should have been applied; | ||
| Other minor adjustments that were not recorded in the originally filed financial statements due to their immateriality; and | ||
| Related tax effects for all items. |
33
34
Non-cash | ||||||||||||||||||||||||
stock option | ||||||||||||||||||||||||
Net earnings as | compensation | Net earnings | ||||||||||||||||||||||
previously reported | expense | Other | Tax effect | Total adjustments | as restated | |||||||||||||||||||
Nine months ended September 30, 2005 |
$ | 129,326 | $ | (2,193 | ) | $ | (2,453 | ) | $ | 1,476 | $ | (3,170 | ) | $ | 126,156 | |||||||||
Three months ended September 30, 2005 |
$ | 7,950 | $ | (803 | ) | $ | | $ | 265 | $ | (538 | ) | $ | 7,412 |
35
Company | Segment | Effective date acquired | ||
Allianz Life Insurance Company Health Products Division
|
Insurance company | October 2, 2006 | ||
G.B. Kenrick & Associates, Inc.
|
Agency | July 1, 2006 | ||
Novia Underwriters, Inc.
|
Agency | June 30, 2006 | ||
Illium Insurance Group
|
Agency | December 31, 2005 | ||
Perico Ltd.
|
Agency | December 1, 2005 | ||
Perico Life Insurance Company
|
Insurance company | November 30, 2005 | ||
HCC International Insurance Company
|
Insurance company | July 1, 2005 | ||
United States Surety Company
|
Insurance company | March 1, 2005 |
36
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | (As restated) | |||||||||||||||
Net earned premium |
81.6 | % | 83.3 | % | 81.5 | % | 82.0 | % | ||||||||
Fee and commission income |
7.1 | 8.4 | 7.5 | 7.8 | ||||||||||||
Net investment income |
7.4 | 5.9 | 7.0 | 6.1 | ||||||||||||
Net realized investment gain (loss) |
(0.1 | ) | 0.2 | 0.1 | | |||||||||||
Other operating income |
4.0 | 2.2 | 3.9 | 4.1 | ||||||||||||
Total revenue |
100.0 | 100.0 | 100.0 | 100.0 | ||||||||||||
Loss and loss adjustment expense, net |
46.7 | 56.9 | 45.7 | 71.8 | ||||||||||||
Policy acquisition costs, net |
15.7 | 15.7 | 15.1 | 15.9 | ||||||||||||
Other operating expense |
10.6 | 11.5 | 11.5 | 10.0 | ||||||||||||
Interest expense |
0.5 | 0.5 | 0.7 | 0.5 | ||||||||||||
Earnings from continuing
operations before income tax
expense |
26.5 | 15.4 | 27.0 | 1.8 | ||||||||||||
Income tax expense |
8.8 | 4.9 | 9.0 | 0.2 | ||||||||||||
Earnings from continuing operations |
17.7 | % | 10.5 | % | 18.0 | % | 1.6 | % | ||||||||
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Gross written premium |
$ | 1,628,213 | $ | 1,540,002 | $ | 536,101 | $ | 525,447 | ||||||||
Net written premium |
1,299,114 | 1,107,443 | 422,581 | 371,698 | ||||||||||||
Net earned premium |
1,204,941 | 995,901 | 421,052 | 338,058 |
37
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | ||||||||||||||||
Agency |
$ | 70,712 | $ | 71,680 | $ | 24,781 | $ | 23,533 | ||||||||
Insurance companies |
33,697 | 29,319 | 14,081 | 8,540 | ||||||||||||
Fee and commission income |
$ | 104,409 | $ | 100,999 | $ | 38,862 | $ | 32,073 | ||||||||
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Fixed income securities |
$ | 81,349 | $ | 56,017 | $ | 29,858 | $ | 19,855 | ||||||||
Short-term investments |
21,817 | 13,899 | 7,792 | 5,468 | ||||||||||||
Other investments |
9,870 | 2,891 | (382 | ) | 482 | |||||||||||
Total investment income |
113,036 | 72,807 | 37,268 | 25,805 | ||||||||||||
Investment expense |
(4,077 | ) | (2,768 | ) | (1,063 | ) | (807 | ) | ||||||||
Net investment income |
$ | 108,959 | $ | 70,039 | $ | 36,205 | $ | 24,998 | ||||||||
38
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Average yield |
4.2 | % | 3.9 | % | 4.3 | % | 3.9 | % | ||||||||
Average tax equivalent yield |
5.2 | % | 4.8 | % | 5.1 | % | 4.8 | % | ||||||||
Weighted average maturity |
7.0 years | 7.6 years | ||||||||||||||
Weighted average duration |
4.8 years | 4.8 years |
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Strategic investments |
$ | 28,057 | $ | 10,085 | $ | 15,308 | $ | 6,872 | ||||||||
Trading securities |
24,161 | 9,210 | 2,307 | 7,783 | ||||||||||||
Financial instruments |
3,265 | 3,250 | 1,273 | 603 | ||||||||||||
Other |
3,588 | 3,571 | 1,388 | 1,606 | ||||||||||||
Other operating income |
$ | 59,071 | $ | 26,116 | $ | 20,276 | $ | 16,864 | ||||||||
39
40
Gross | Net | NWP as | Net | |||||||||||||
written | written | % of | earned | |||||||||||||
premium | premium | GWP | premium | |||||||||||||
Nine months ended September 30, 2006 |
||||||||||||||||
Diversified financial products |
$ | 690,779 | $ | 574,098 | 83 | % | $ | 538,063 | ||||||||
Group life, accident and health |
415,215 | 388,895 | 94 | 385,257 | ||||||||||||
Aviation |
166,072 | 128,810 | 78 | 112,661 | ||||||||||||
London market account |
202,964 | 111,278 | 55 | 80,455 | ||||||||||||
Other specialty lines |
152,960 | 96,056 | 63 | 88,569 | ||||||||||||
Discontinued lines |
223 | (23 | ) | nm | (64 | ) | ||||||||||
Totals |
$ | 1,628,213 | $ | 1,299,114 | 80 | % | $ | 1,204,941 | ||||||||
Nine months ended September 30, 2005 |
||||||||||||||||
Diversified financial products |
$ | 665,400 | $ | 480,405 | 72 | % | $ | 371,414 | ||||||||
Group life, accident and health |
453,558 | 381,367 | 84 | 380,681 | ||||||||||||
Aviation |
159,446 | 99,879 | 63 | 101,817 | ||||||||||||
London market account |
124,134 | 64,938 | 52 | 66,402 | ||||||||||||
Other specialty lines |
133,766 | 78,542 | 59 | 69,574 | ||||||||||||
Discontinued lines |
3,698 | 2,312 | nm | 6,013 | ||||||||||||
Totals |
$ | 1,540,002 | $ | 1,107,443 | 72 | % | $ | 995,901 | ||||||||
Three months ended September 30, 2006 |
||||||||||||||||
Diversified financial products |
$ | 240,046 | $ | 200,333 | 83 | % | $ | 189,744 | ||||||||
Group life, accident and health |
142,457 | 130,007 | 91 | 129,234 | ||||||||||||
Aviation |
50,976 | 38,446 | 75 | 40,430 | ||||||||||||
London market account |
44,799 | 20,761 | 46 | 31,590 | ||||||||||||
Other specialty lines |
57,837 | 32,963 | 57 | 30,033 | ||||||||||||
Discontinued lines |
(14 | ) | 71 | nm | 19 | |||||||||||
Totals |
$ | 536,101 | $ | 422,581 | 79 | % | $ | 421,050 | ||||||||
Three months ended September 30, 2005 |
||||||||||||||||
Diversified financial products |
$ | 241,781 | $ | 184,931 | 76 | % | $ | 143,084 | ||||||||
Group life, accident and health |
147,236 | 124,358 | 84 | 125,079 | ||||||||||||
Aviation |
53,090 | 31,597 | 60 | 35,008 | ||||||||||||
London market account |
32,366 | (370 | ) | nm | 8,784 | |||||||||||
Other specialty lines |
49,991 | 30,220 | 60 | 25,023 | ||||||||||||
Discontinued lines |
983 | 962 | nm | 1,080 | ||||||||||||
Totals |
$ | 525,447 | $ | 371,698 | 71 | % | $ | 338,058 | ||||||||
| Diversified financial products Growth in our surety and credit products was strong from both organic growth and our 2005 acquisitions. The growth in net written and net earned premium was due to increased retentions resulting from a reduction in proportional reinsurance. | ||
| Group life, accident and health Gross written premium declined primarily because we non- |
41
renewed a book of business which was 100% reinsured. Profit margins remain at acceptable levels despite competition from the fully insured market. |
| Aviation The growth in net written and net earned premium was due to the effect of recapture of ceded unearned premium from a transfer of in force business in the second quarter of 2006. In addition, retentions increased from a reduction in proportional reinsurance. | ||
| London market account Gross written premium increased due to the substantial increase in rates in the energy sector as a result of the 2005 hurricane losses, more than offsetting a reduction in our property sector premium. Net written premium increased for the same reason and will be reflected in increases in our net earned premium later in 2006 and into 2007. In 2006, to increase our capacity and spread our risk in the energy sector, we entered into a new quota share reinsurance agreement. Although the cost of our 2006 excess of loss reinsurance increased, our potential profitability is greater on the increased gross written premium. Our aggregate exposure in Florida and the Gulf of Mexico is lower in 2006 than it was in 2005. Net written premium and net earned premium were reduced in 2005 by additional excess of loss premium to reinstate catastrophe reinsurance coverage, which distorts the retention percentages. | ||
| Other specialty lines We experienced organic growth in our other specialty lines of business from increased writings in several products. The mix of products affected the retention percentages. Rates in this line have been relatively stable. |
42
Nine months ended September 30, | Three months ended September 30, | |||||||||||||||||||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||||||||||||||||||
Net | Net | Net | Net | Net | Net | Net | Net | |||||||||||||||||||||||||
earned | loss | earned | loss | earned | loss | earned | loss | |||||||||||||||||||||||||
premium | ratio | premium | ratio | premium | ratio | premium | ratio | |||||||||||||||||||||||||
(As restated) | ||||||||||||||||||||||||||||||||
Diversified
financial products |
$ | 538,063 | 49.0 | % | $ | 371,414 | 48.1 | % | $ | 189,744 | 46.5 | % | $ | 143,084 | 48.5 | % | ||||||||||||||||
Group life, accident
and health |
385,257 | 71.3 | 380,681 | 73.0 | 129,234 | 73.7 | 125,079 | 78.9 | ||||||||||||||||||||||||
Aviation |
112,661 | 55.9 | 101,817 | 73.3 | 40,430 | 55.0 | 35,008 | 100.0 | ||||||||||||||||||||||||
London market account |
80,455 | 44.5 | 66,402 | 95.1 | 31,590 | 42.9 | 8,784 | 424.3 | ||||||||||||||||||||||||
Other specialty lines |
88,569 | 58.1 | 69,574 | 76.1 | 30,033 | 55.2 | 25,023 | 111.2 | ||||||||||||||||||||||||
Discontinued lines |
(64 | ) | nm | 6,013 | nm | 19 | nm | 1,080 | nm | |||||||||||||||||||||||
Totals |
$ | 1,204,941 | 57.2 | % | $ | 995,901 | 68.3 | % | $ | 421,050 | 56.1 | % | $ | 338,058 | 87.5 | % | ||||||||||||||||
Expense ratio |
25.7 | 26.2 | 24.5 | 25.3 | ||||||||||||||||||||||||||||
Combined ratio |
82.9 | % | 94.5 | % | 80.6 | % | 112.8 | % | ||||||||||||||||||||||||
| Aviation Underwriting results have been better than expected in 2006. The 2005 hurricanes increased the loss ratios 8.2% and 24.1% for the nine months and third quarter of 2005, respectively. | ||
| London market account The 2005 hurricanes increased the loss ratios 54.9% and 393.3% for the nine months and third quarter of 2005, respectively. The London market account line of business can have relatively high quarter-to-quarter volatility due to catastrophe exposure. | ||
| Other specialty lines The 2005 hurricanes increased the net loss ratios 18.6% and 51.8% for the nine months and third quarter of 2005, respectively. | ||
| Discontinued lines The 2005 commutation losses primarily affected this line of business. |
43
44
Nine months ended | Three months ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
(As restated) | (As restated) | |||||||||||||||
Net earnings |
$ | 261,543 | $ | 126,156 | $ | 93,257 | $ | 7,412 | ||||||||
Change in premium, claims and other
receivables, net of reinsurance, other
payables and restricted cash |
(79,176 | ) | (67,328 | ) | (28,950 | ) | 47,397 | |||||||||
Change in unearned premium, net |
109,051 | 103,503 | 4,837 | 32,106 | ||||||||||||
Change in loss and loss adjustment
expense payable, net of reinsurance
recoverables |
149,937 | 376,060 | 36,521 | 270,187 | ||||||||||||
Change in trading portfolio |
(99,193 | ) | (54,654 | ) | (14,702 | ) | (16,600 | ) | ||||||||
Other, net |
17,544 | (30,483 | ) | 8,802 | (6,085 | ) | ||||||||||
Cash provided by operating activities |
$ | 359,706 | $ | 453,254 | $ | 99,765 | $ | 334,417 | ||||||||
45
46
47
48
49
| Before the Board of Directors reviewed the results of the investigation, the Chairman of our Compensation Committee tendered his resignation from the Board of Directors on November 8, 2006. After reviewing the results of the investigation, our Board of Directors determined that it would be appropriate to accept the resignations of our former CEO and General Counsel, which both tendered on November 17, 2006. Our Board of Directors has appointed a new Chairman of our Compensation Committee and a new CEO who, together with other members of our senior management, are committed to achieving transparency through effective corporate governance, a strong control environment, application of business standards reflected in our Code of Business Conduct and Ethics, and completeness and integrity of our financial reporting and disclosure. | ||
| We have changed our option granting approval policies and procedures to require Compensation Committee approval of all new option grants on the day of each Compensation Committee meeting preceding the regularly scheduled quarterly Board of Directors meeting. All grants will be appropriately approved and documented in minutes of the meeting, taken contemporaneously with the meeting. All grants will be priced at the market closing price on the day of each such Compensation Committee meeting. We have established processes and procedures to increase the level of communication between the Compensation Committee, senior management and our financial reporting and accounting personnel regarding stock option grants. |
a. | Exhibits | |||
23 | Consent of Independent Registered
Public Accounting Firm PricewaterhouseCoopers LLP dated December 22, 2006 |
|||
31.1 | Certification by Chief Executive Officer |
|||
31.2 | Certification by Chief Financial Officer |
|||
32.1 | Certification with Respect to Quarterly Report |
50
HCC Insurance Holdings, Inc. | ||
(Registrant) | ||
December 26, 2006 | /s/ Frank J. Bramanti | |
(Date) | Frank J. Bramanti, Chief Executive Officer | |
December 26, 2006 | /s/ Edward H. Ellis, Jr. | |
(Date) | Edward H. Ellis, Jr., Executive Vice President and Chief Financial Officer |
51
23 | Consent of Independent Registered
Public Accounting Firm PricewaterhouseCoopers LLP dated December 22, 2006 |
|||
31.1 | Certification by Chief Executive Officer |
|||
31.2 | Certification by Chief Financial Officer |
|||
32.1 | Certification with Respect to Quarterly Report |